« Previous
Next »
Titles
- 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff1
- A close look at Medi-Cal managed care: quality, access, and the provider's experience under geographic managed care1
- A close look at Medi-Cal managed care: statewide quality trends from the last decade1
- A close look at Medi-Cal managed care: stories of quality improvement success1
- A national comparison of operative outcomes of new and experienced surgeons1
- ACOs' strategies for transitioning to value-based care: lessons from the Medicare shared savings program1
- Acceptance and filing reviews for premarket approval applications (PMAs): guidance for industry and Food and Drug Administration staff1
- Access to health insurance1
- Accountability in the Medi-Cal managed care program1
- Adaptive designs for clinical trials of drugs and biologics1
- Administrative rulemaking1
- Age-friendly Brooklyn1
- Amyotrophic lateral sclerosis: developing drugs for treatment1
- Are humans the problem in patient safety?1
- Assessing 'first visits' by physicians to Medicare patients discharged to skilled nursing facilities1
- Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion1
- Bacterial vaginosis: developing drugs for treatment1
- Behavioral health integration in Medi-Cal: a blueprint for California1
- Behavioral health integration: treating the whole person1
- Benefits and services1